Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS study.

Phlebology Pub Date : 2024-10-01 Epub Date: 2024-05-30 DOI:10.1177/02683555241257840

Carmen K Dietrich, Tobias Hirsch, Karsten Hartmann, Thomas Mattausch, Hans-Christian Wenzel, Philipp Zollmann, Jürgen Veltman, Thomas K Weiler, Guido Lengfellner, Lars Müller, Markus Stücker, Felizitas Pannier, Lorenz Uhlmann, Christine Müller-Christmann

{"title":"Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS study.","authors":"Carmen K Dietrich, Tobias Hirsch, Karsten Hartmann, Thomas Mattausch, Hans-Christian Wenzel, Philipp Zollmann, Jürgen Veltman, Thomas K Weiler, Guido Lengfellner, Lars Müller, Markus Stücker, Felizitas Pannier, Lorenz Uhlmann, Christine Müller-Christmann","doi":"10.1177/02683555241257840","DOIUrl":null,"url":null,"abstract":"Background: The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation.Methods: Among 1173 patients with refluxing GSV, 604 underwent GSV-ablation only, and 569 received additional ASV-ablation. Complication rates were compared over 6 months.Results: Approximately 80% of patients were complication-free with minor bruising and dysesthesia being most common complications. After 6 months, additional prophylactic ASV-ablation did not increase the rate of complications compared to GSV-only treatment.Conclusion: The 6-months follow-up data suggests that prophylactic ASV-closure, alongside GSV-treatment, is safe, with similar complication rates to GSV-only EVLA.","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"585-591"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phlebology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/02683555241257840","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation.

Methods: Among 1173 patients with refluxing GSV, 604 underwent GSV-ablation only, and 569 received additional ASV-ablation. Complication rates were compared over 6 months.

Results: Approximately 80% of patients were complication-free with minor bruising and dysesthesia being most common complications. After 6 months, additional prophylactic ASV-ablation did not increase the rate of complications compared to GSV-only treatment.

Conclusion: The 6-months follow-up data suggests that prophylactic ASV-closure, alongside GSV-treatment, is safe, with similar complication rates to GSV-only EVLA.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

大隐静脉热消融术患者大隐静脉前段同步预防性消融的安全性--SYNCHRONOUS 研究 6 个月的随访数据。

背景：SYNCHRONOUS研究调查了在静脉腔内激光消融术（EVLA）中同时进行ASV消融和大隐静脉（GSV）治疗以预防静脉曲张复发的情况。本子研究探讨了与预防性 ASV 消融术相关的并发症发生率：在1173名GSV反流患者中，604人仅接受了GSV消融术，569人接受了额外的ASV消融术。结果：大约 80% 的患者在 6 个月内没有出现并发症：结果：约 80% 的患者无并发症，最常见的并发症是轻微瘀伤和疼痛。6个月后，与单纯GSV治疗相比，额外的预防性ASV消融并没有增加并发症的发生率：6个月的随访数据表明，预防性ASV闭合术与GSV治疗是安全的，并发症发生率与单纯GSV EVLA相似。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Phlebology

自引率

0.00%

发文量